S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

Genprex News Headlines (NASDAQ:GNPX)

$0.36
0.00 (0.00 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$0.35
Now: $0.36
$0.37
50-Day Range
$0.24
MA: $0.29
$0.42
52-Week Range
$0.23
Now: $0.36
$2.26
Volume305,500 shs
Average Volume1.15 million shs
Market Capitalization$6.94 million
P/E RatioN/A
Dividend YieldN/A
Beta1.28

Headlines

Genprex (NASDAQ GNPX) News Headlines

Source:
DateHeadline
Short Interest in Genprex Inc (NASDAQ:GNPX) Increases By 7.8%Short Interest in Genprex Inc (NASDAQ:GNPX) Increases By 7.8%
www.americanbankingnews.com - January 15 at 4:46 PM
Genprex to Present at Biotech Showcase™ 2020 in San FranciscoGenprex to Present at Biotech Showcase™ 2020 in San Francisco
finance.yahoo.com - January 6 at 4:33 PM
Genprex Announces $1.26 Million Registered Direct OfferingGenprex Announces $1.26 Million Registered Direct Offering
finance.yahoo.com - November 20 at 1:52 PM
BRIEF-Genprex Reports Positive Preclinical Data For The Treatment Of Lung CancerBRIEF-Genprex Reports Positive Preclinical Data For The Treatment Of Lung Cancer
www.msn.com - November 19 at 7:33 PM
Genprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung CancersGenprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung Cancers
finance.yahoo.com - November 19 at 9:21 AM
Genprex Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness MonthGenprex Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month
finance.yahoo.com - November 4 at 8:09 AM
Genprex to Present at the MicroCap Rodeo Investor ConferenceGenprex to Present at the MicroCap Rodeo Investor Conference
finance.yahoo.com - October 9 at 1:49 PM
Genprex’s Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry SupportGenprex’s Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry Support
finance.yahoo.com - October 7 at 9:07 AM
Genprex (GNPX) Featured in Audio Publication Discussing New Research on Breast Cancer TreatmentGenprex (GNPX) Featured in Audio Publication Discussing New Research on Breast Cancer Treatment
finance.yahoo.com - September 26 at 9:42 AM
Genprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer TreatmentsGenprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer Treatments
finance.yahoo.com - September 25 at 4:49 PM
Gene Therapies with Potential to Conquer Tough-to-Tackle Breast CancersGene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers
www.marketwatch.com - September 24 at 4:24 PM
Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019
finance.yahoo.com - September 19 at 9:23 PM
Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast CancerIndependent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer
finance.yahoo.com - September 11 at 10:54 AM
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy TreatmentsGenprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
finance.yahoo.com - September 6 at 2:46 PM
Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech SectorGenprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
finance.yahoo.com - August 23 at 11:48 AM
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone AchievementsGenprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
finance.yahoo.com - August 22 at 10:38 AM
What Kind Of Investor Owns Most Of Genprex, Inc. (NASDAQ:GNPX)?What Kind Of Investor Owns Most Of Genprex, Inc. (NASDAQ:GNPX)?
finance.yahoo.com - August 21 at 4:37 PM
Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech SectorRecord Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector
www.finanznachrichten.de - August 21 at 10:42 AM
Genprex to Present at the RHK Capital 4th Annual Disruptive Growth ConferenceGenprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference
finance.yahoo.com - August 21 at 10:42 AM
Genprex Demonstrates Growth and Expansion Through Recent AchievementsGenprex Demonstrates Growth and Expansion Through Recent Achievements
finance.yahoo.com - August 13 at 11:44 AM
Genprex™ Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex™ Clinical Development ProgramGenprex™ Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex™ Clinical Development Program
finance.yahoo.com - August 6 at 12:07 PM
Genprex Begins Next Phase of Drug Branding ProgramGenprex Begins Next Phase of Drug Branding Program
finance.yahoo.com - July 31 at 1:00 PM
5 Immunotherapy Stocks to Keep a Close Eye On5 Immunotherapy Stocks to Keep a Close Eye On
finance.yahoo.com - July 9 at 3:57 PM
Genprex preparing study of Oncoprex in lung cancerGenprex preparing study of Oncoprex in lung cancer
seekingalpha.com - July 1 at 3:53 PM
Genprex Provides Update on Development of its Oncoprex Immunogene Therapy in Combination with Immunotherapy for Non-Small Cell Lung CancerGenprex Provides Update on Development of its Oncoprex Immunogene Therapy in Combination with Immunotherapy for Non-Small Cell Lung Cancer
finance.yahoo.com - July 1 at 11:14 AM
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer TreatmentGenprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
finance.yahoo.com - May 31 at 11:34 AM
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy BreakthroughsGenprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs
www.nasdaq.com - May 30 at 11:38 AM
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs  Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs  
finance.yahoo.com - May 30 at 11:38 AM
Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment ForumGenprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
finance.yahoo.com - May 21 at 12:46 PM
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene TherapiesGenprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
finance.yahoo.com - May 9 at 11:44 AM
Genprex Retains Addison Whitney for Drug Nomenclature BrandingGenprex Retains Addison Whitney for Drug Nomenclature Branding
finance.yahoo.com - May 8 at 11:48 AM
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer TreatmentGenprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
finance.yahoo.com - May 8 at 11:48 AM
Genprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the IncurableGenprex (GNPX) Featured in NetworkNewsAudio Broadcast Discussing Gene Therapy Programs on the Cusp of Curing the Incurable
finance.yahoo.com - April 12 at 1:40 PM
Genprex Featured in NetworkNewsAudio Broadcast on Potential Gene Therapy Treatment for CancerGenprex Featured in NetworkNewsAudio Broadcast on Potential Gene Therapy Treatment for Cancer
finance.yahoo.com - April 12 at 1:40 PM
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy TreatmentGenprex (GNPX) Featured in NetworkNewsWire Publication Discussing Cancer and Gene Therapy Treatment
finance.yahoo.com - April 11 at 4:03 PM
Genprex (GNPX) Featured in NetworkNewsWire Publication about Revolutionary Gene TherapiesGenprex (GNPX) Featured in NetworkNewsWire Publication about Revolutionary Gene Therapies
finance.yahoo.com - April 11 at 4:03 PM
Genprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual MeetingGenprex Collaborators Report Positive TUSC2 and Checkpoint Blockade Preclinical Data at the 2019 AACR Annual Meeting
www.businesswire.com - April 8 at 9:04 AM
Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018Genprex Provides Clinical, Corporate, and Financial Update for the Year Ending December 31, 2018
finance.yahoo.com - April 1 at 1:06 PM
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer TherapyGenprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Advanced Medical Cancer Therapy
finance.yahoo.com - March 29 at 12:23 PM
Genprex Featured in NetworkNewsAudio Publication on Unprecedented Targeting in Cancer TreatmentGenprex Featured in NetworkNewsAudio Publication on Unprecedented Targeting in Cancer Treatment
finance.yahoo.com - March 29 at 12:23 PM
Genprex Featured in NetworkNewsWire Publication on Innovations in Cancer TherapyGenprex Featured in NetworkNewsWire Publication on Innovations in Cancer Therapy
finance.yahoo.com - March 28 at 12:31 PM
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer TreatmentsGenprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
finance.yahoo.com - March 28 at 12:31 PM
Genprex IncGenprex Inc
www.bloomberg.com - March 19 at 12:14 PM
Genprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWireGenprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWire
finance.yahoo.com - March 19 at 12:14 PM
NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.’s Innovative Approach to Gene TherapyNetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.’s Innovative Approach to Gene Therapy
finance.yahoo.com - March 15 at 12:10 PM
NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.'s Transformative Work in Gene TherapyNetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.'s Transformative Work in Gene Therapy
finance.yahoo.com - March 15 at 12:10 PM
NetworkNewsWire Announces Publication on Gene Therapys Promise for Improving Patient Treatments and Market ProfitabilityNetworkNewsWire Announces Publication on Gene Therapy's Promise for Improving Patient Treatments and Market Profitability
www.marketwatch.com - March 14 at 12:14 PM
NetworkNewsWire Announces Publication on Gene Therapy’s Promise for Improving Patient Treatments and Market ProfitabilityNetworkNewsWire Announces Publication on Gene Therapy’s Promise for Improving Patient Treatments and Market Profitability
finance.yahoo.com - March 14 at 12:14 PM
Genprex to Present at ARM Cell & Gene Therapy Investor Day in New York CityGenprex to Present at ARM Cell & Gene Therapy Investor Day in New York City
finance.yahoo.com - March 14 at 12:14 PM
Genprex Strengthens Senior Team and Continues to Advance OperationsGenprex Strengthens Senior Team and Continues to Advance Operations
finance.yahoo.com - February 27 at 12:05 PM
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Featured Article: Diluted Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel